Showing results (451-460 of 551) with videos related to

Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancerM Duvic, B Helekar, C Schulz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakiaJames L Mulshine, Jane C Atkinson, Robert O Greer, et al.
Plos One|September 3, 2010
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancerMichelle A T Hildebrandt, Ritsuko Komaki, Zhongxing Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p lossWilliam N William, Xin Zhao, Joy J Bianchi, et al.
Cancer Research|September 10, 2009
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer developmentWoo-Young Kim, Quanri Jin, Seung-Hyun Oh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reductionKala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|March 21, 2014
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancerK D Crew, K A Ho, P Brown, et al.
Pageof 56